drugset / Trial / NCT01220817
Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
When given to men with recurrent prostate cancer, the investigators hypothesize that POMx is effective in slowing the rise of PSA as measured by PSA doubling time in men following initial therapy for prostate cancer. Further, the investigators believe that POMx will be shown to be safe and well tolerated.
Timeline
- Start
- 2007-10
- Primary completion
- 2010-05
- Completion
- 2010-05